New study sheds light on patients’ experiences in ATTR care
A new study explores the real-world experiences of patients with ATTR, highlighting diagnostic delays and unmet care needs.
A new study explores the real-world experiences of patients with ATTR, highlighting diagnostic delays and unmet care needs.
A new study shows CRT upfront improves survival for patients with ATTR-CM who have high pacing needs, even in advanced disease stages.
Measuring TTR levels before and during tafamidis treatment may help predict mortality and heart failure risks in ATTR-CM.
The Phase 3 MAGNITUDE trial of nex-z in ATTR-CM can now proceed following a clinical hold placed by the FDA due to a case of liver injury.
Physical labor and agricultural work may increase the risk of ATTRwt-CM, potentially triggering amyloid buildup in the heart.
The ATTR-QOL is a validated tool that can be applied in clinical settings to measure disease severity and impact, a recent study found.
Scientists succeeded in incorporating AI into the CA diagnostic process.
A 62-year-old man received a heart transplant which contained amyloid deposits caused by ATTR-CM, ultimately leading to heart failure.
Both cardiac and noncardiac conditions can increase the risk of death in people with ATTR-CM, new research finds.
Changes in the eyes may help doctors diagnose transthyretin amyloid cardiomyopathy (ATTR-CM) in its early stages.